If you liked this article you might like

Mylan Dispute Puts More Biotechs in Danger
Stock Futures Head Lower as Jobless Claims Decline, Durable Goods Increase
Mallinckrodt's Top Drug Could Go the Way of EpiPen
5 Things You Must Know Before the Market Opens Thursday